High-Value Cancer Care and the Problem With Surrogate Endpoints in the Quality/Cost Equation

Journal of the National Comprehensive Cancer Network : JNCCN - United States
doi 10.6004/jnccn.2019.7372
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Harborside Press, LLC

Related search

Cancer Drug Wastage: The Hidden Cost in Value-Based Cancer Care Delivery

Cancer
Cancer ResearchOncology
2017English

Solving the Value Equation in Health Care

Health Affairs
MedicineHealth Policy
2013English

Surrogate and Intermediate Endpoints in Randomized Trials: What's the Goal?

Clinical Cancer Research
Cancer ResearchOncology
2018English

Uncertainty in the Bayesian Meta-Analysis of Normally Distributed Surrogate Endpoints

Statistical Methods in Medical Research
Health Information ManagementEpidemiologyStatisticsProbability
2015English

High-Value Palliative Care for Cancer Patients

AMA journal of ethics
Health PolicyEthicsHealthIssuesLegal Aspects
2015English

Quality Is Not the Only Part of the Emergency Department–Based Intensive Care Unit Value Equation

JAMA network open
Medicine
2019English

Statistical Evaluation of Surrogate Endpoints in Clinical Studies

2014English

A Causal Framework for Surrogate Endpoints With Semi-Competing Risks Data

Statistics and Probability Letters
UncertaintyStatisticsProbability
2012English

A Perspective on Surrogate Endpoints in Controlled Clinical Trials

Statistical Methods in Medical Research
Health Information ManagementEpidemiologyStatisticsProbability
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy